July 10, 2020

meet the medics who will share in £8million funding to research short and long term health issues for patients hospitalised with COVID

On Sunday Matt Hancock announced the launch of a major £8.4 million research study into the long-term health effects of COVID-19 on hospitalised patients,

Post-Hospitalisation COVID-19 Study (PHOSP-COVID), led by the NIHR Leicester Biomedical Research Centre, will bring together a group of fantastic clinical scientists from across the UK to assess the impact of COVID-19 on patient health and recovery.

The SMC invited some of those scientists to talk to science journalists about their different roles in this study and brief them on what research questions they will focus on in coming months, their concerns about short and long term health issues they are seeing in patients who have been hospitalised,  and answer any questions about what can be expected to learn and when from their research. 

Speakers included:

Prof Calum Semple, Professor in Child Health and Outbreak Medicine, University of Liverpool

Prof Chris Brightling, Clinical Professor in Respiratory Medicine, University of Leicester

Dr Rachael Evans, Consultant Respiratory Physician and Honorary Senior Lecturer, University of Leicester

Prof John Geddes, Professor of Epidemiological Psychiatry, University of Oxford

Prof Louise Wain, GSK / British Lung Foundation Chair in Respiratory Research, University of Leicester